Empowering patients through shared knowledge and community-driven health insights.
The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
© 2026 MedInfo World. All rights reserved.
Elvitegravir – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Category
Cytochrome P450 3A Inhibitor [EPC]
Cytochrome P450 3A Inhibitor [EPC] Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
Important Notice This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Elvitegravir.
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Cytochrome P450 3A Inhibitors [MoA] P-Glycoprotein Inhibitors [MoA] Cytochrome P450 2D6 Inhibitors [MoA] Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA] Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA] Breast Cancer Resistance Protein Inhibitors [MoA] Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA] HIV Integrase Inhibitors [MoA] Cytochrome P450 2C9 Inducers [MoA] Nucleoside Reverse Transcriptase Inhibitors [MoA]
RxCUI
1721613, 1721619, 1306292, 1306298
UNII
LW2E03M5PG, 4GDQ854U53, G70B4ETF4S, FWF6Q91TZO, OTT9J7900I